Rossmax International Ltd. (TPEX:4121)
Taiwan · Delayed Price · Currency is TWD 19.35
+0.55 (2.93%)
Mar 5, 2026, 1:30 PM CST
Rossmax International Revenue
In the year 2025, Rossmax International had annual revenue of 3.80B TWD, down -1.34%. Rossmax International had revenue of 950.93M in the quarter ending December 31, 2025, a decrease of -1.93%.
Revenue
3.80B
Revenue Growth
-1.34%
P/S Ratio
0.42
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.80B | -51.80M | -1.34% |
| Dec 31, 2024 | 3.85B | 42.10M | 1.11% |
| Dec 31, 2023 | 3.81B | -535.69M | -12.33% |
| Dec 31, 2022 | 4.34B | 397.05M | 10.06% |
| Dec 31, 2021 | 3.95B | 268.93M | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 3.41B |
| Wellell | 2.39B |
| OK Biotech | 1.64B |
| Dynamic Medical Technologies | 1.43B |
| AViTA | 896.85M |
| Bioptik Technology Incorporation | 829.18M |
| Diamond Biotechnology | 698.11M |
| Applied BioCode | 443.69M |